Skip to main content

Life Sciences

HIMSS22
By Emily Olsen | 03:01 pm | February 16, 2022
In a preview of her HIMSS22 session, Abbott's Jennifer Jones-McMeans explains how clinical studies can be structured to ensure a diverse population of participants.
By Emily Olsen | 03:36 pm | February 15, 2022
Also: Complex-care-management platform Memora Health and digital-fitness startup FitOn both raised $40 million.
By Adam Ang | 12:17 am | February 15, 2022
The telehealth service is expanding across Asia two years since its launch in Singapore.
By Emily Olsen | 01:14 pm | February 14, 2022
The continuous glucose monitoring system can be used to measure glucose levels in adults with diabetes for up to six months.
By Dr. Liz Kwo | 11:44 am | February 11, 2022
Precision genomics could impact the payer, provider and life science space. 
By Tammy Lovell | 08:17 am | February 11, 2022
Also, HCA Healthcare UK opens £26M specialist oncology unit at UCLH.
By Adam Ang | 10:18 pm | February 10, 2022
Also, Genesis MedTech has acquired Chinese valve replacement device maker JC Medical.
By Laura Lovett | 04:04 pm | February 08, 2022
Tryl is focused on curbing clinical trial dropout rates through personalized patient engagement. 
By Laura Lovett | 03:26 pm | February 07, 2022
The new partnership is focused on expanding access to clinical trials for patients from diverse backgrounds. 
By Emily Olsen | 12:38 pm | February 07, 2022
The company helps patients find clinical trials and works with pharma companies to limit barriers to enrollment.